top of page

A legal and policy advocacy organization that educates the public and policymakers about the rule of law and constitutionally limited government.
Anchor 1
The Latest


Protecting Property, Not Regulating Markets: Why Reining In Proxy Advisors Is Essential
In The National Law Review, CFJ's Ashley Baker argues that reining in dominant proxy advisory firms protects shareholders' property rights.
Ashley Baker


CFJ Weighs In on How to Restore America’s Scientific and Innovation Leadership
American technological leadership results from secure property rights driving risk taking not from centralized planning or regulatory micromanagement.
Jeffrey Depp


Surface Transportation Board, Don't Be a Third Rail
In The Washington Times, CFJ's Jeffrey Depp argues that the STB should approve the Union Pacific–Norfolk Southern merger based on dynamic competition, not size.
Jeffrey Depp


Re: Revision to the Rules of Practice Before the Patent Trial and Appeal Board (PTAB)
These proposed reforms—particularly the restrictions on serial and parallel inter partes review (“IPR”) challenges and the requirement that petitioners stipulate to litigating validity in only one forum—represent an urgently needed course-correction to restore reliability to U.S. patent rights, strengthen American innovation, and fortify the nation’s technological leadership against foreign adversaries, especially the People’s Republic of China.
Jeffrey Depp


A Federal AI Moratorium Is the America-First Policy the Constitution Requires
State attempts to regulate artificial intelligence violate the Commerce Clause and risk crippling U.S. innovation. Congress must pass a federal moratorium to preempt state fragmentation and promote AI development.
Ashley Baker


Europe Cannot Legislate Technological Supremacy
In RealClearMarkets, CFJ's Jeffrey Depp argues that the EU's Digital Markets Act punishes scale and success and stifles the innovation Europe says it wants.
Jeffrey Depp


The NIH 'Access Plan' Mandate: Central Planning by Another Name
In Truth on the Market, CFJ's Jeffrey Depp argues that NIH's “access plan” mandate for patent licenses is central planning that threatens biomedical innovation.
Jeffrey Depp


Amicus Brief in Support of Supreme Court Application for Stay of Injunction in Epic v. Google Antitrust Appeal
Amicus brief of the Committee for Justice filed in Epic v. Google antitrust appeal argues that the lower court injunction violates longstanding antitrust precedent, will result in irreparable harm and is against the public interest.
Ashley Baker


Don't Tax Innovation: The Patent 'Wealth Tax' Is a Terrible Idea
In National Review, CFJ's Jeffrey Depp argues that a fee on patent value would be an unconstitutional, unapportioned property tax that discourages innovation.
Jeffrey Depp
bottom of page
